ArticleIDCases2025
Neurobrucellosis manifested by recurrent aseptic meningitis: A case report.
Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brucellosis is an endemic zoonotic disease in LMIC countries. Neurobrucellosis is a rare and serious complication that affects 3-5 % of cases worldwide. We report the successful treatment of a 31-year-old woman who presented with a chief complaint of headache and nausea. Headache was started six months before admission in the frontal and occipital area with radiation to the neck. The patient hospitalized three times within last six months with diagnosis of aseptic meningitis. Brucellosis, tuberculosis, and syphilis tests and CSF fluid analysis were requested. Neutrophilia and pleocytosis in CSF fluid. Analysis of CSF fluid for cytology and PCR test for HSV-1&2 was negative. Rheumatologic tests for SLE, Behcet's disease and sarcoidosis were also negative. Test results was as follow: Wright: 1/320, Coombs Wright: 1/640, 2ME: 1/160, Brucella IgG: 25(Positive). According to the test results, combined treatment with rifampin, Co-trimoxazole, and ceftriaxone was performed for neurobrucellosis for nine months. Considering the endemic prevalence of brucellosis in this region, the rare manifestations of this disease should be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.